Philip Morris International Inc

Analysts expect Altria to report revenues of $5.08 billion in the second quarter of 2020—a fall of 2.2% from $5.19 billion in the second quarter of 2019.

Philip Morris stock has risen as much as 3.2% in the pre-market session today as of 8:55 AM ET. The company posted its second-quarter results.

This year, Philip Morris stock has been subdued, losing 13.6% of its value. The company is set to report its second-quarter earnings on July 21.

Today, Gaurav Jain of Barclays downgraded Altria Group (NYSE:MO) from “overweight” to “equal weight.” He also lowered his target price from $50 to $43.

On Tuesday, the FDA authorized Philip Morris’s IQOS, an electrically heated tobacco unit, to be marketed as a modified risk tobacco product.

So far this year, Philip Morris (NYSE:PM) has lost 17.0% of its stock value. The stock has underperformed the broader equity markets.

So far this year, Philip Morris International (NYSE:PM) and Altria Group (NYSE:MO) have underperformed the broader equity markets.

Despite the impressive first-quarter performance, Philip Morris’s stock price has declined. As of May 7, the company was trading at $70.14.

Currently, 14 analysts cover Altria stock. Many analysts have a bullish view on the stock due to its higher dividend yield and lower valuation.

Philip Morris reported its earnings results for the first quarter of 2020. The company reported an adjusted EPS of $1.21 on revenues of $7.15 billion.

As of April 13, Philip Morris (NYSE:PM) was trading at 73.95—a fall of 11.3% since the announcement of its fourth-quarter earnings on February 6.

Investors should find safety in high-yielding dividend stocks amid the downturn. Altria and Philip Morris both deliver stable earnings and constant dividends.

On March 16, Morgan Stanley upgraded Altria Group (NYSE:MO) from “equal weight” to “overweight” with a target price of $49.

As of March 10, Philip Morris (PM) was trading at $84.73—a fall of 0.4% since the beginning of this year. PM has outperformed the broader equity market and its peers.

As of March 6, Altria Group (NYSE:MO) was trading at $42.15—a fall of 15.9% since the company reported its earnings for the fourth quarter of 2020 on January 30.

Today, Philip Morris reported its fourth-quarter earnings. For the quarter, the company posted an adjusted EPS of $1.22 on revenues of $7.71 billion.

Philip Morris will report its Q4 earnings before the market opens on Thursday. Analysts expect the company’s revenue to rise and its adjusted EPS to fall. 

Today, Altria Group reported its fourth-quarter earnings, which ended on December 31. For the quarter, the company reported revenue of $6.0 billion.

In addition to boosting dividends, many consumer stocks saw stellar growth in 2019. Most of these companies outperformed the benchmark index YTD.

Most consumer stocks have outperformed the broader markets so far this year amid an improved macroeconomic backdrop and the industry’s defensive nature.

In this morning’s edition of our daily market newsletter, Get Real, we looked at Trump’s new tariff targets, a 5G network launch, and turnaround hopes.

Citigroup has upgraded Altria and downgraded Philip Morris. It expects lower cigarette volume declines and has a favorable outlook on traditional tobacco.

Altria (MO) stock has recovered recently and risen by about 8% in a month. However, the stock has underperformed peers and broader markets this year.

At the end of the third quarter, Bristol-Myers Squibb, Celgene, Biogen, UnitedHealth, and Walmart (WMT) were Renaissance Technologies’ top five buys.

When Altria posted its earnings yesterday, things looked positive. However, after news about Juul Labs, MO stock lost momentum and closed 2.6% lower.

Altria (MO) posted better-than-expected third-quarter earnings results today. As expected, lower cigarette shipment volumes remained a drag.

Altria (MO) is scheduled to report its third-quarter earnings results on October 31. Analysts expect its earnings to continue to improve year-over-year.

Altria stock has recovered sharply in October. There’s positive momentum in the stock before the company’s earnings. The stock has risen 14% in October.

On October 18, Citigroup upgraded Altria stock to “neutral” from “sell.” It expects the negative news surrounding vaping to boost cigarette volumes.

Philip Morris reported mixed third-quarter results before the markets opened. The company posted revenues of $7.64 billion—up 1.8% YoY.

Philip Morris will announce its third-quarter earnings results on October 17. We believe the pressure on the company’s top line could ease a bit.

Since the lower stock price dented investors’ return, Altria has rewarded its shareholders through higher dividends and share repurchases.

Behemoth tobacco companies Philip Morris (PM) and Altria (MO) might be getting back together after separating more than a decade ago.

Altria (MO) stock has lagged the broader market in 2019. On August 17, the CDC noted that it is investigating lung diseases linked to e-cigarette use.

As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.

Altria Group (MO) is set to report its second-quarter earnings before the market opens on July 30. In the quarter, analysts expect the company’s revenue and EPS to rise.

Philip Morris International (PM) reported its second-quarter earnings results on Thursday. The company reported adjusted EPS of $1.46.

On Thursday, Philip Morris reported its second-quarter earnings results. It reported adjusted EPS of $1.46 on revenue of $7.70 billion.

Philip Morris is scheduled to announce its second-quarter earnings results before the market opens on July 18. Analysts expect its revenue and EPS to fall.

On Friday, Goldman Sachs upgraded Altria Group (MO) from a “neutral” to a “buy” while keeping its price target unchanged at $59.

The fall of 9.5% in Philip Morris International’s (PM) stock price since the announcement of its first-quarter earnings has led to a decline in its valuation multiple as well.

Philip Morris International (PM) was trading at $77.38, which represents a fall of 9.5% since its first-quarter earnings on April 18.

Altria Group (MO) reported its first-quarter earnings on April 25.

On May 28, Altria Group (MO) fell 4.8%, while British American Tobacco (BTI) fell 4.1%.

Today, Philip Morris International (PM) was trading ~0.8% higher at 11:05 AM EST.

Today, Bank of America upgraded Philip Morris International (PM) from “underperform” to “neutral” and also raised its price target from $81 to $94.

For the first quarter of 2019, Altria Group (MO) has posted revenue, net of excise tax, of $4.39 billion against analysts’ estimate of $4.59 billion.

Altria failed to meet analysts’ revenue and EPS expectations for the first quarter.

Despite strong first-quarter results, Philip Morris was trading in the red early on April 18.

Analysts expect Philip Morris International (PM) to post revenue of $6.74 billion in the first quarter.

Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.

The FDA’s announcement caused Altria’s stock price to fall. On April 3, the stock price fell to a low of $53.43 before closing the day at $53.98.

Sin stocks marked healthy growth in the first quarter. Molson Coors and Brown-Forman stocks rose 6.2% and 10.9%, respectively.

The Consumer Staples Select Sector SPDR ETF (XLP) rose 10.5% in the first quarter of 2019.

For 2019, analysts are expecting Philip Morris International (PM) to post revenue of $30.68 billion, which represents a rise of 3.6% from $29.63 billion in 2018.

Philip Morris International (PM) posted a net revenue excluding excise tax of $29.63 billion in 2018.

On March 8, Altria (MO) announced that it completed its previously announced investment of ~$1.8 billion in Cronos Group.

For 2019, analysts expect Philip Morris International (PM) to report revenue of $30.69 billion, which represents growth of 3.6% from $29.63 billion in 2018.

The strengthening broader equity market and strong fourth-quarter earnings have increased Philip Morris’s (PM) stock price, which has led to an increase in its valuation multiple.

After losing 36.8% of its stock value in 2018, Philip Morris International (PM) began 2019 on a strong note.

According to a Bloomberg report on February 22, JUUL Lab’s management expects its revenues to rise to $3.4 billion in 2019.

George Soros added 2.026 million shares of the SPDR Select Sector Fund (XLF) to its portfolio during the fourth quarter, giving it a weight of 1.5% in the portfolio.

In the third quarter of fiscal 2019, Pyxus International (PYX) posted revenue of $524.5 million, a rise of 9.8% year-over-year.

Pyxus International (PYX) posted its fiscal 2019 third-quarter earnings results after the market closed on February 11.

Altria Group (MO) posted its fourth-quarter earnings on January 31. During the quarter, the company’s EPS met analysts’ expectations.

In the fourth quarter, Philip Morris International (PM) posted revenue of $7.50 billion, outperforming analysts’ expectation of $7.39 billion.

In the fourth quarter, Philip Morris outperformed analysts’ EPS estimate of $1.16 and revenue estimate of $7.39 billion.

Philip Morris International (PM) posted its fourth-quarter earnings on February 7. The company posted an adjusted EPS of $1.25.

Since the beginning of 2019, Cowen and Company, Goldman Sachs, and Morgan Stanley have all lowered their price targets on PM stock.

Analysts expect Philip Morris International (PM) to post revenue of $7.38 billion in the fourth quarter.

Philip Morris International (PM) is scheduled to post its fourth-quarter earnings results before the market opens on February 7.

The optimism surrounding Altria Group’s (MO) recent investments in Juul and Cronos Group (CRON) has led to a rise in Altria’s stock price, which in turn has raised its valuation multiple.

Altria Group (MO) posted adjusted EPS of $0.95 in the fourth quarter, which represents growth of 4.4% from $0.91 in the corresponding quarter of 2017.

The segment has posted revenue of $4.1 billion, which represents a rise of 1.9% from $3.94 billion in the fourth quarter of 2017.

For the fourth quarter, analysts are expecting Altria Group (MO) to post adjusted EPS of $0.95, which represents a rise of 4.4% from $0.91 in the corresponding quarters of 2017.

For the fourth quarter, analysts are expecting Altria Group (MO) to post revenue of $4.81 billion, which represents a rise of 2.1% from $4.71 billion in the corresponding quarter of 2017.

Altria Group (MO) is scheduled to post its fourth-quarter earnings before the market opens on January 31.

On January 22, Morgan Stanley downgraded Altria from “equal weight” to “underweight.” Morgan Stanley lowered the target price from $54 to $45.

Today, Cowen and Company downgraded Altria Group (MO) from “outperform” to “market perform” due to the accelerating decline in Altia’s cigarette sales.

Among the 17 analysts that cover Altria Group (MO), 51.9% recommended a “buy” rating as of December 27.

As of December 27, Altria Group (MO) was trading at $48.70—a fall of 21.8% since its third-quarter earnings on October 25.

Today, Altria Group (MO) announced a $12.8 billion investment in Juul Labs for a stake of 35% in the e-cigarette company.

Today, Reuters reported that Credit Suisse downgraded Philip Morris International (PM) from “neutral” to “underperform” and lowered its price target to $74 from $92.

In the first three quarters of 2018, Altria Group (MO) posted adjusted EPS of $3.04, which represents growth of 22.6% from $2.48 in the corresponding three quarters of the previous year.

Altria Group is all set to leverage growth opportunities in the cannabis space with its decision to buy a stake in Cronos Group.

As of November 21, Altria was trading at $54.39—a fall of 12.7% since the announcement of its third-quarter earnings on October 25.

In the third quarter, Philip Morris International (PM) posted revenue of $7.50 billion, outperforming analysts’ expectation of $7.17 billion.

Philip Morris International (PM) plans to announce its Q3 earnings on October 18. Philip Morris’s stock price has declined by 22.1% YTD.

As of September 17, Altria Group (MO) stock was trading at $62.44, which represents a 7.9% rise since July 26.

The potential ban on flavored e-cigarettes to be favorable for Altria Group (MO), Philip Morris International (PM), and British American Tobacco (BTI).

Since the beginning of 2018, Philip Morris stock has fallen 24.6% due to an increase in tobacco regulations, a decline in cigarette shipment volumes, and rising competition.

As of August 21, Philip Morris was trading at a forward PE multiple of 15.7x compared to 14.9x before its announcement of its second-quarter earnings.

On July 27, Altria Group (MO) was trading at $57.90. On the same day, analysts set their average price target for the company at $67.24.

Philip Morris International (PM) reported its Q2 earnings on July 19, posting adjusted EPS of $1.41 on revenues of $7.73 billion.

Philip Morris International (PM) reported its second-quarter results today and lowered its 2018 EPS guidance.

Altria’s forward PE multiple has declined since the beginning of 2018. As of July 13, Altria was trading at a forward PE multiple of 14.0x.

Philip Morris (PM) plans to release its Q2 earnings on July 19. On July 11, PM stock traded at $82.84, down 18.3% from its Q1 earnings.

Investors shunned the stocks of tobacco companies in the first half of 2018 following the decline in shipment volumes.

The Consumer Staples Select Sector SPDR ETF (XLP) fell 9.4% in the first six months of 2018.